CDNA
CareDx, Inc
NASDAQ · USHealthcareMedical - Diagnostics & Research
$38.37-3.42%
Price as of Jul 20, 2026
CDNA profitability
CareDx, Inc profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 68.6%
- EBITDA margin
- 2.6%
- EBIT margin
- -3.2%
- Net margin
- -2.0%
- Free cash flow margin
- 15.8%
Returns
- Return on equity
- -2.6%
- Return on assets
- -2.0%
- Return on invested capital
- -3.9%
- Asset turnover
- 1.00x
Cash efficiency
- Cash from operations
- $72.9M
- Cash per share
- $3.62
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.